The Effect of COVID-19 on Hematological Disease Diagnosis, Management and Outcomes

79K

views

75

authors

12

articles

Editorial

13 April 2023

Editorial: The effect of COVID-19 on hematological disease diagnosis, management and outcomes

Mohamed Yassin

,

Ahmed Adel Elsabagh

,

Duygu Aydemir

and

Yasser Wali

1,533 views

0 citations

Editors

3

Mohamed A Yassin

Qatar University

College of Medicine and Health Science, Sultan Qaboos University

Koç University

Impact

About

The coronavirus disease 2019 (COVID-19) is an infectious disease that has become a global public health concern since December 2019. It causes mild to severe respiratory illness with some flu-like symptoms and people with secondary diseases are considered a major risk group. Despite vaccination, people are still infected and died because of COVID-19 infection.

Patients with haematological disorders (e.g., sickle cell anemia, thalassemia) are more vulnerable to COVID-19 due to their clinical complications. Such patients are generally more prone to such viral and bacterial infections, which can worsen their physical condition when combined with COVID-19 infection. Further, some of these patients present immunocompromised conditions, e.g., post-transplant patients.

There is a need to synthesize the impact of COVID-19 for physicians and health care professionals to continue effective management for such patients through this continuing pandemic.

This research topic will address the effect of COVID-19 on the diagnosis, management strategies, and outcomes of patients with haematological disorders.

The coronavirus disease 2019 (COVID-19) is an infectious disease that has become a global public health concern since December 2019. It causes mild to severe respiratory illness with some flu-like symptoms and people with secondary diseases are considered a major risk group. Despite vaccination, people are still infected and died because of COVID-19 infection.

Patients with haematological disorders (e.g., sickle cell anemia, thalassemia) are more vulnerable to COVID-19 due to their clinical complications. Such patients are generally more prone to such viral and bacterial infections, which can worsen their physical condition when combined with COVID-19 infection. Further, some of these patients present immunocompromised conditions, e.g., post-transplant patients.

There is a need to synthesize the impact of COVID-19 for physicians and health care professionals to continue effective management for such patients through this continuing pandemic.

This research topic will address the effect of COVID-19 on the diagnosis, management strategies, and outcomes of patients with haematological disorders.

Download ebook

Share

Editors

Mohamed A Yassin

Qatar University

College of Medicine and Health Science, Sultan Qaboos University

Koç University

Impact

79,035 Total views

68,287 Article views

9,428 Article downloads

1,320 Topic views

Published In

Journal Thumbnail

Frontiers in Medicine

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic